CVMP advice on injection-site fibrosarcomas in cats

Veterinary Record

Volumn 152, Issue 13, 2003, Pages 381-382

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM; FELINE LEUKEMIA VIRUS VACCINE; INACTIVATED VACCINE; LIVE VACCINE; RABIES VACCINE; VACCINE; VETERINARY DRUG; VIRUS VACCINE;

ARTICLE; CANCER RISK; CAT; DRUG ADMINISTRATION ROUTE; DRUG CARCINOGENICITY; DRUG EFFICACY; DRUG INDUCED CANCER; DRUG SAFETY; FIBROSARCOMA; HUMAN; INJECTION SITE; MEDICAL INFORMATION; NONHUMAN; REVACCINATION; RISK BENEFIT ANALYSIS; VACCINATION REACTION; VETERINARY MEDICINE;

FELIDAE; FELINE LEUKEMIA VIRUS; FELIS CATUS;

EID: 0037471892     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. DODDY, F. D., GLICKMAN, L. T., GLICKMAN, N. W. & JANOWITZ, E. B. (1996) Feline fibrosarcomas at vaccination and non-vaccination sites. Journal of Comparative Pathology 114, 165-174
2. GASKELL, R., GETTINBY, G., GRAHAM, S. & SKILTON, D. (2002) Veterinary Products Committee Report on Feline and Canine Vaccination. Final Report. London, DEFRA Publications. (A summary of this document was published in The Veterinary Record, February 2, 2002, pp 126-134, and the whole report containing an up-to-date review of the literature on the subject is available at www.vpc.gov.uk)
3. MACY, D. W. (1999) Current understanding of vaccination site-associated sarcomas in the cat. Journal of Feline Medicine and Surgery 1, 15-21